Experts from across the EU are meeting today to exchange approaches and tools to better prepare for emerging health and security threats. The virtual meeting, hosted by the European Union Drugs Agency (EUDA), and opened by its Executive Director Dr Lorraine Nolan, takes place under the agency’s presidency of the EU Justice and Home Affairs Agencies’ Network (JHAAN).
Bringing together EU agencies and European Commission representatives (DG-HOME, DG-SANTE, JRC, HERA), the event focuses on improving readiness for cross-border threats under this year’s JHAAN presidency theme: ‘One Safety —…
Čtěte více
The European Union Agencies Network on Scientific Advice (EU-ANSA) has reaffirmed the central role of EU agencies in supporting research and translating scientific knowledge into evidence-based policymaking, through a Joint statement signed by the Chief Scientists or highest-ranking scientific officers of member agencies.
Drawing on experience from recent crises, such as COVID-19, EU-ANSA highlights how EU agencies contribute across the research knowledge cycle – from identifying policy-relevant knowledge gaps and shaping research priorities, to supporting the uptake of research results in…
Čtěte více
The European Commission has taken a major step to introduce EU-wide controls on nine high-risk precursor chemicals used in illicit drug production via new legislation published this week. The Delegated Regulation (EU) 2026/314 (1) builds on the findings of the first EU-level precursor assessments carried out by the European Union Drugs Agency (EUDA) in 2025 (see news item).
Eight of the precursors in question are linked to the production of four synthetic cathinones (3-CMC, 3-MMC, 4-CMC, 4-MMC), while one substance (phenyl-2-nitropropene) is used in amphetamine production.
The regulation…
Čtěte více
